Whole-body MRI for the Detection of Metastasis (WBMRI)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02183597 |
Recruitment Status :
Withdrawn
First Posted : July 8, 2014
Last Update Posted : August 10, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Breast Cancer Metastases |
Study Type : | Observational |
Actual Enrollment : | 0 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Whole-body MRI for the Detection of Metastasis |
Study Start Date : | March 2016 |
Estimated Primary Completion Date : | March 2018 |
Estimated Study Completion Date : | March 2018 |

Group/Cohort |
---|
Advanced breast cancer
Women with advanced breast cancer
|
- Number of metastasis in skeleton [ Time Frame: Baseline and after 6 months ]Number of skeleton metastasis will be assessed at the regular clinical follow-up of breast cancer patients with metastatic disease

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 95 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Cancer patient
Exclusion Criteria:
- Poor general condition
- Pacemaker or other MRI contraindications

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02183597
Principal Investigator: | Beathe Sitter, PhD | Norwegian University of Science and Technology |
Responsible Party: | Norwegian University of Science and Technology |
ClinicalTrials.gov Identifier: | NCT02183597 History of Changes |
Other Study ID Numbers: |
STUC-2013-WBMRI-Sitter |
First Posted: | July 8, 2014 Key Record Dates |
Last Update Posted: | August 10, 2016 |
Last Verified: | August 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Keywords provided by Norwegian University of Science and Technology:
Magnetic Resonance Imaging Data Accuracy Reproducibility of Results Diagnosis |
Additional relevant MeSH terms:
Neoplasm Metastasis Neoplastic Processes Neoplasms Pathologic Processes |